Search
Janux Therapeutics Inc
JANXAdd to Watchlist
15.540USD
+0.880+6.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
945.85MMarket Cap
LossP/E TTM
Janux Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Janux Therapeutics Inc is 7.59, ranking 214 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -8.44, which is -52.69% below the recent high of -3.99 and -576.87% above the recent low of -57.11.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.